These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35085175)
1. Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma. Mavi ME; Turan BS; Salanci BV; Bozkurt MF Clin Nucl Med; 2022 May; 47(5):e395-e396. PubMed ID: 35085175 [TBL] [Abstract][Full Text] [Related]
2. Therapy Response in a Pediatric Patient With Extracutaneous Juvenile Xanthogranuloma Monitored by FDG PET/CT. Wen Z; Zhuang H Clin Nucl Med; 2020 Apr; 45(4):303-305. PubMed ID: 32049719 [TBL] [Abstract][Full Text] [Related]
3. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group]. Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of congenital systemic juvenile xanthogranulomatosis with pulmonary involvement. Ataseven E; Kizmazoglu D; Oniz H Pediatr Dermatol; 2021 Jul; 38(4):892-894. PubMed ID: 33998710 [TBL] [Abstract][Full Text] [Related]
5. Utility of Chandekar KR; Satapathy S; Sharma A; Taneja N; Tripathi M; Bal C J Nucl Med Technol; 2023 Dec; 51(4):335-336. PubMed ID: 37699645 [TBL] [Abstract][Full Text] [Related]
6. Serial 18 F-FDG PET/CT Revealing Mixed Histiocytosis in a Pediatric Patient. Singh K; Lau L; Wegner EA; Rossleigh MA; Shon IH Clin Nucl Med; 2024 Oct; 49(10):e518-e520. PubMed ID: 39150359 [TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic Multicentric Reticulohistiocytosis on 18F-FDG PET/CT Breast Carcinoma Follow-up. Dietz M; Debarbieux S; Righetti M; Harou O; Tordo J Clin Nucl Med; 2021 May; 46(5):e253-e255. PubMed ID: 33323726 [TBL] [Abstract][Full Text] [Related]
8. A Rare Widespread Cutaneous Langerhans Cell Histiocytosis Manifested on 18 F-FDG PET/CT. Wang L; Zhang Y; Wu H Clin Nucl Med; 2022 Oct; 47(10):e647-e648. PubMed ID: 35543631 [TBL] [Abstract][Full Text] [Related]
10. Benign cephalic histiocytosis progressing into juvenile xanthogranuloma: a non-Langerhans cell histiocytosis transforming under the influence of a virus? Rodriguez-Jurado R; Duran-McKinster C; Ruiz-Maldonado R Am J Dermatopathol; 2000 Feb; 22(1):70-4. PubMed ID: 10698221 [TBL] [Abstract][Full Text] [Related]
11. Subdural effusion in a CNS involvement of systemic juvenile xanthogranuloma: a case report treated with vinblastin. Auvin S; Cuvellier JC; Vinchon M; Defoort-Dhellemes S; Soto-Ares G; Nelken B; Vallée L Brain Dev; 2008 Feb; 30(2):164-8. PubMed ID: 17720345 [TBL] [Abstract][Full Text] [Related]
12. Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693 [TBL] [Abstract][Full Text] [Related]
18. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports. Patrizi A; Neri I; Bianchi F; Guerrini V; Misciali C; Paone G; Burnelli R Dermatology; 2004; 209(1):57-61. PubMed ID: 15237270 [TBL] [Abstract][Full Text] [Related]
19. The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report. Asano T; Suzutani K; Watanabe A; Honda A; Mori N; Yashiro M; Sato S; Kobayashi H; Watanabe H; Hazama M; Kanno T; Suzuki E; Ishii S; Migita K Medicine (Baltimore); 2018 Aug; 97(33):e11449. PubMed ID: 30113451 [TBL] [Abstract][Full Text] [Related]
20. Juvenile xanthogranuloma with angiomatous appearance and a peculiar immunophenotype. López-Robles J; Núñez L; Macias-Del-Toro E; Ramírez-Bellver JL; Díaz JL; Requena L Pediatr Dermatol; 2018 Jan; 35(1):e55-e56. PubMed ID: 29165834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]